1TMO Stock Overview

Provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. More details

1TMO fundamental analysis
Snowflake Score
Valuation	4/6
Future Growth	3/6
Past Performance	5/6
Financial Health	3/6
Dividends	0/6

Rewards

Price-To-Earnings ratio (23.6x) is below the Life Sciences industry average (31.4x)

Earnings are forecast to grow 10.08% per year

Earnings grew by 8% over the past year

Trading at good value compared to peers and industry

Analysts in good agreement that stock price will rise by 39.8%

Risk Analysis

Has a high level of debt

Significant insider selling over the past 3 months

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

Thermo Fisher Scientific Inc. Competitors

Danaher

NYSE:DHR

US$136.0b

Fine Foods & Pharmaceuticals N.T.M

BIT:FF

€176.3m

Recordati Industria Chimica e Farmaceutica

BIT:REC

€10.9b

Lonza Group

SWX:LONN

CHF 40.8b

Price History & Performance

Summary of share price highs, lows and changes for Thermo Fisher Scientific
Historical stock prices
Current Share Price	US$359.35
52 Week High	US$551.20
52 Week Low	US$372.60
Beta	0.83
1 Month Change	-8.91%
3 Month Change	-35.38%
1 Year Change	-32.73%
3 Year Change	-28.52%
5 Year Change	14.90%
Change since IPO	28.59%

Recent updates

Shareholder Returns

	1TMO	IT Life Sciences	IT Market
7D	-4.5%	-1.1%	2.0%
1Y	-32.7%	-7.0%	11.8%

Return vs Industry: 1TMO underperformed the Italian Life Sciences industry which returned -4.3% over the past year.

Return vs Market: 1TMO underperformed the Italian Market which returned 12.2% over the past year.

Price Volatility

Is 1TMO's price volatile compared to industry and market?
1TMO volatility
1TMO Average Weekly Movement	4.0%
Life Sciences Industry Average Movement	6.7%
Market Average Movement	5.4%
10% most volatile stocks in IT Market	8.7%
10% least volatile stocks in IT Market	3.3%

Stable Share Price: 1TMO has not had significant price volatility in the past 3 months compared to the Italian market.

Volatility Over Time: 1TMO's weekly volatility (4%) has been stable over the past year.

About the Company

Founded	Employees	CEO	Website
1956	125,000	Marc Casper	www.thermofisher.com

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company’s Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery and production of drugs and vaccines, as well as diagnosis of infections and diseases. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories.

Thermo Fisher Scientific Inc. Fundamentals Summary

How do Thermo Fisher Scientific's earnings and revenue compare to its market cap?
1TMO fundamental statistics
Market cap	€135.82b
Earnings (TTM)	€5.76b
Revenue (TTM)	€37.92b

23.6x

P/E Ratio

3.6x

P/S Ratio

Is 1TMO overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
1TMO income statement (TTM)
Revenue	US$42.90b
Cost of Revenue	US$25.12b
Gross Profit	US$17.78b
Other Expenses	US$11.26b
Earnings	US$6.51b

Last Reported Earnings

Mar 29, 2025

Next Earnings Date

n/a

Earnings per share (EPS)	17.26
Gross Margin	41.44%
Net Profit Margin	15.18%
Debt/Equity Ratio	68.8%

How did 1TMO perform over the long term?

See historical performance and comparison

Dividends

0.4%

Current Dividend Yield

9%

Payout Ratio

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/05/07 06:22
End of Day Share Price	2025/05/07 00:00
Earnings	2025/03/29
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Thermo Fisher Scientific Inc. is covered by 53 analysts. 28 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Kadambari Daptardar	Accountability Research Corporation
David Toung	Argus Research Company
Catherine Ramsey Schulte	Baird